Argus lowered the firm’s price target on Iqvia (IQV) to $260 from $280 but keeps a Buy rating on the shares. The company delivered strong new-order growth in Q3, and looking ahead, the firm expects it to benefit from its sizable backlog and new technology offerings, the analyst tells investors in a research note. Based on Iqvia’s industry leadership, revenue visibility, recent contract wins, and history of technological innovation, Argus expects continued growth for the company in the coming quarters.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IQV: